login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
NEUROMETRIX INC (NURO) Stock News
USA
- NASDAQ:NURO -
US6412558800
-
Common Stock
4.58
USD
+0.22 (+5.05%)
Last: 5/1/2025, 9:21:09 PM
4.53
USD
-0.05 (-1.09%)
After Hours:
5/1/2025, 9:21:09 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
NURO Latest News, Press Relases and Analysis
All
Press Releases
2 months ago - By: Yahoo Finance
- Mentions:
UBER
TSLA
LCID
GOOG
Uber, Lucid partner on new robotaxi service, taking on Waymo and Tesla
2 months ago - By: Bloomberg
- Mentions:
UBER
LCID
Uber Partnering With Lucid, Nuro to Launch Robotaxis in 2026
8 months ago - By: Kahn Swick & Foti, LLC
NEUROMETRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NeuroMetrix, Inc. - NURO
9 months ago - By: NeuroMetrix, Inc.
NeuroMetrix to be Acquired by electroCore
10 months ago - By: NeuroMetrix, Inc.
NeuroMetrix Reports Q3 2024 Business Highlights
a year ago - By: InvestorPlace
NURO Stock Earnings: NeuroMetrix Reported Results for Q2 2024
9 months ago - By: Halper Sadeh LLC
- Mentions:
CARA
ARCH
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NURO, CARA, ARCH on Behalf of Shareholders
9 months ago - By: Halper Sadeh LLC
NURO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NeuroMetrix, Inc. Is Fair to Shareholders
a year ago - By: BusinessInsider
NURO Stock Earnings: NeuroMetrix Reported Results for Q1 2024
a year ago - By: InvestorPlace
NURO Stock Earnings: NeuroMetrix Reported Results for Q1 2024
a year ago - By: NeuroMetrix, Inc.
NeuroMetrix Reiterates its Review of Strategic Alternatives
a year ago - By: NeuroMetrix, Inc.
NeuroMetrix Reports Q2 2024 Business Highlights and Update on Review of Strategic Options
a year ago - By: NeuroMetrix, Inc.
NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call
a year ago - By: NeuroMetrix, Inc.
NeuroMetrix Reports Q1 2024 Business Highlights
a year ago - By: Benzinga
- Mentions:
RGC
CCM
ICU
ANL
...
12 Health Care Stocks Moving In Friday's Intraday Session
a year ago - By: NeuroMetrix, Inc.
NeuroMetrix Announces Steps Taken to Enhance Shareholder Value
2 years ago - By: NeuroMetrix, Inc.
NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy
2 years ago - By: NeuroMetrix, Inc.
NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia
2 years ago - By: NeuroMetrix, Inc.
NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights
2 years ago - By: Benzinga
- Mentions:
XPEL
ZIP
PKST
VICR
...
Earnings Scheduled For February 22, 2024
2 years ago - By: NeuroMetrix, Inc.
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call
2 years ago - By: Seeking Alpha
NeuroMetrix announces review of strategic options for business growth (NASDAQ:NURO)
2 years ago - By: NeuroMetrix, Inc.
NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value
2 years ago - By: NeuroMetrix, Inc.
NeuroMetrix to Present at the Emerging Growth Conference on January 10, 2024
2 years ago - By: NeuroMetrix, Inc.
NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell® in Post-Acute COVID-19 Syndrome (Long COVID)
2 years ago - By: NeuroMetrix, Inc.
NeuroMetrix Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Showing that Quell® Improves Painful Symptoms of Chemotherapy Induced Peripheral Neuropathy (CIPN)
2 years ago - By: NeuroMetrix, Inc.
NeuroMetrix Announces One-for-Eight Reverse Stock Split
2 years ago - By: NeuroMetrix, Inc.
NeuroMetrix to Present at the Emerging Growth Conference on November 1, 2023
2 years ago - By: NeuroMetrix, Inc.
NeuroMetrix Reports Q3 2023 Business Highlights
2 years ago - By: NeuroMetrix, Inc.
NeuroMetrix, Inc. Announces Date for Third Quarter 2023 Business and Financial Highlights Conference Call
2 years ago - By: NeuroMetrix, Inc.
NeuroMetrix and the National Fibromyalgia Association to Collaborate to Improve the Quality of Life for People Living with Fibromyalgia
Please enable JavaScript to continue using this application.